地西他滨加改良CAG方案联合人白细胞抗原半相合淋巴细胞输注治疗老年急性髓系白血病缓解1例
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Decitabine and modified CAG regimen combined with human leukocyte antigen-haploidentical lymphocyte infusion successfully induces remission in elderly acute myeloid leukemia: one case report
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    骨髓增生异常综合征(MDS)是一组造血干细胞异常的恶性克隆性疾病,可转化为急性髓系白血病(AML)。MDS转化为AML时,化疗常常不能有效杀灭或抑制肿瘤细胞,且骨髓抑制相当严重,化疗后骨髓抑制期的出血、感染常成为患者临床死亡主要原因。因此,继发于MDS的AML患者预后差,治疗困难。近期笔者应用地西他滨加阿糖胞苷、阿克拉霉素和粒细胞集落刺激因子(CAG)联合半相合淋巴细胞回输,成功诱导缓解1例继发于MDS的AML,并显著缩短化疗后的骨髓抑制期,获得良好疗效。

    Abstract:

    Myelodysplastic syndrome (MDS) is a group of malignant clone diseases owing to hematopoietic stem cell abnormality, which can transform to acute myeloblastic leukemia (AML). After MDS transforms to AML, the leukemia cells usually can not be effectively killed or inhibited, and bone marrow suppression becomes fairly severe. After chemotherapy, hemorrhage and infection in the period of bone marrow suppression are usually the main reasons for mortality. Therefore, the AML patients secondary to MDS usually have poor prognosis and are difficult to treat. Recently, we utilized decitabine and regimen of cytarabine, aclacinomycin and granulocyte-colony stimulating factor (CAG) combined with haploidentical lymphocyte infusion to treat a 62-year-old male with MDS-transformed AML. The symptoms were successfully remitted, with markedly shortened bone marrow suppression and favorable outcome.

    参考文献
    相似文献
    引证文献
引用本文

冯少美,王志红,靖 彧,杨清明*.地西他滨加改良CAG方案联合人白细胞抗原半相合淋巴细胞输注治疗老年急性髓系白血病缓解1例[J].中华老年多器官疾病杂志,2014,13(04):296-299
DOI:10.3724/SP. J.1264.2014.00069

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-04-25
  • 出版日期:
文章二维码